Skip to main content

Table 1 Demographic data, clinical and laboratory parameters of human subjects involved in the study

From: Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis

Parameter

Lupus nephritis

SLE without nephritis

Healthy controls

Sum

16

18

24

Gender

Female

Female

Female

Age: Mean (SD) [range] years

33 (6.5) [24–42]

39 (8.7) [20–50]

28 (7.1) [21–50]

Race/ethnicity

 Caucasian

12 (75%)

18 (100%)

24 (100%)

 Asian

1 (6.2%)

0 (0%)

0 (0%)

 Other races

3 (18.7%)

0 (0%)

0 (0%)

 NR

1 (6.2%)

0 (0%)

0 (0%)

Pyuria (WBC/μl) [Mean (SD), range]

41.4 (58.3) [10–166]

Proteinuria (g/L) [Mean (SD), range]

1.52 (1.2) [0.05–3.58]

Urinary creatinine (mg/dL) [Mean, (SD) range]

123.9 (66.2) [51–262]

GFR [Mean, (SD) range]

94.1 (41.5) [29–168]

C3 (mg/L) [Mean (SD), range]

0.77 (0.2) [0.5–1.25]

CRP (mg/L) [Mean (SD), range]

9 (10.9) [< 1–28]

Serum creatinine (mg/dL) [Mean (SD), range]

0.85 (0.4) [0.45–1.94]

Serum albumin (g/L) [Mean (SD), range]

22 (17.8) [3.3–44.1]

SLEDAI

8.7 (5.8) [0–21]

LN class

 II/III

1 (6.2%)

 III

2 (12.5%)

 III/ IV

2 (12.5%)

 IV

8 (50%)

 V

1 (6.2%)

 NR

2 (12.5%)

Flare status

  

 YES

5 (31.3%)

2 (11.1%)

 NO

11 (68.7%)

16 (88.9%)

Medication

 Corticosteroids

15 (93.7%)

13 (72.2%)

 Immunosuppressant

14 (87.5%)

10 (55.6%)

 Anti-malarial

15 (93.7%)

17 (94.4%)

  1. NR not reported, GFR glomerular filtration rate, C3 complement component 3, CRP C-reactive protein, WBC white blood cells, SLEDAI SLE disease activity index